Physician
Nielan, Gary
Nielan, Gary was paid $119K by Medicaid between Mar 2018 and Mar 2023, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.
33Billing provider infoNIELAN, GARY
WILBRAHAM, MA 01095
WILBRAHAM, MA 01095
33aNPI1568458479assigned 09/26/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$119K
24GClaims3,633
24DCodes billed14
24AFirst – last monthMar 2018 – Mar 2023
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in Massachusetts
Rank by total paid#28 of 54
Median peer was paid$119K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 330 | $10K | |
| 2019 | 655 | $26K | |
| 2020 | 520 | $18K | |
| 2021 | 724 | $26K | |
| 2022 | 1,110 | $30K | |
| 2023 | 294 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 32% | 435 | 410 | $38K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 31% | 691 | 683 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.6% | 201 | 200 | $10K |
| 96127 | 5.8% | 506 | 449 | $7K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.7% | 227 | 227 | $7K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 3.5% | 467 | 467 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.5% | 180 | 179 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.9% | 41 | 41 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.6% | 150 | 150 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.3% | 175 | 169 | $3K |
| 94760 | <1% | 521 | 505 | $1K | |
| 0071A | <1% | 12 | 12 | $550.56 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.